Archives

ENHANCED LTD AND A PARADISE ACQUISITION CORP. ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT ON FORM S-4 IN CONNECTION WITH PROPOSED BUSINESS COMBINATION

B Extraordinary General Meeting of A Paradise Shareholders to Approve Business Combination Scheduled for May 1, 2026 Upon Closing, Combined Company Expected to Be Named… Login to continue reading Login…

Read MoreENHANCED LTD AND A PARADISE ACQUISITION CORP. ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT ON FORM S-4 IN CONNECTION WITH PROPOSED BUSINESS COMBINATION

Bracco Affirms ASNC Position Statement Elevating Cardiac PET with Myocardial Blood Flow as Preferred Standard for Coronary Artery Disease

B Guidance validates the comprehensive approach Bracco has advanced for more than three decades NEEDHAM, Mass., April 13, 2026 /PRNewswire/ — Bracco, the market leader in… Login to continue reading Login…

Read MoreBracco Affirms ASNC Position Statement Elevating Cardiac PET with Myocardial Blood Flow as Preferred Standard for Coronary Artery Disease

A Visual Tribute to Trevor Paglen to be Featured in the Heart of New York, London, and Seoul to Celebrate the 2026 LG Guggenheim Award

B LG presents celebratory visual tributes at New York’s Times Square, London’s Piccadilly Circus, and Seoul’s Gwanghwamun. The campaign highlights the major cities that have… Login to continue reading Login…

Read MoreA Visual Tribute to Trevor Paglen to be Featured in the Heart of New York, London, and Seoul to Celebrate the 2026 LG Guggenheim Award

As GLP-1 Drugs Reshape Global Eating Habits, Meala FoodTech Bridges the Nutrition Gap with a Single-Ingredient Protein Solution

B Israeli ingredient company’s texturized pea protein enables food manufacturers to reformulate products with shorter ingredient lists, higher protein content, and better texture, addressing the… Login to continue reading Login…

Read MoreAs GLP-1 Drugs Reshape Global Eating Habits, Meala FoodTech Bridges the Nutrition Gap with a Single-Ingredient Protein Solution

UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting

B UCB will present additional studies and data analyses highlighting UCB’s ongoing commitment to improving outcomes for people living with gMG Two studies assessed the… Login to continue reading Login…

Read MoreUCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting